Lobe Sciences Ltd (LOBE.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 08-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 210 | N/A | N/A | N/A | N/A |
| Accounts receivable | -325 | -4 | 0 | 0 | 2 |
| Accounts payable and accrued liabilities | 382 | N/A | 0 | 0 | -1 |
| Other Working Capital | -323 | 121 | 0 | 1 | 1 |
| Other Operating Activity | -1,988 | -144 | -52 | -46 | -63 |
| Operating Cash Flow | $-2,044 | $-27 | $-52 | $-45 | $-60 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | -199 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -265 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -5 |
| Investing Cash Flow | $-464 | $N/A | $N/A | $0 | $-5 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,074 | 0 | 47 | N/A | N/A |
| Other Financing Activity | -600 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $475 | $0 | $47 | $N/A | $N/A |
| Exchange Rate Effect | 59 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 2,487 | 30 | 35 | 79 | 144 |
| End Cash Position | 513 | 3 | 30 | 35 | 79 |
| Net Cash Flow | $-2,033 | $-27 | $-5 | $-45 | $-65 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,044 | -27 | -52 | -45 | -60 |
| Capital Expenditure | -265 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -2,309 | -27 | -52 | -45 | -60 |